GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Respiratorius AB (XSAT:RESP) » Definitions » Short-Term Debt

Respiratorius AB (XSAT:RESP) Short-Term Debt : kr0.00 Mil (As of Dec. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Respiratorius AB Short-Term Debt?

Respiratorius AB's Short-Term Debt for the quarter that ended in Dec. 2024 was kr0.00 Mil.

Respiratorius AB Short-Term Debt Historical Data

The historical data trend for Respiratorius AB's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Respiratorius AB Short-Term Debt Chart

Respiratorius AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Respiratorius AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Apr22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Respiratorius AB Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Respiratorius AB Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Respiratorius AB's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Respiratorius AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Respiratorius AB (XSAT:RESP) » Definitions » Short-Term Debt
Comparable Companies
XSAT:PHAL OSTO:CMOTEC B XSAT:DBP B OSTO:QUIA OSTO:NANECH OSTO:STABL OSTO:MODTX XSAT:APTA OSTO:SPRINT OSTO:FLUI VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
Scheelevagen 2, Medicon Village, Lund, SWE, 223 81
Website
https://www.respiratorius.com
Respiratorius AB develops pharmaceutical drugs to treat the common diseases namely Cancer, Chronic Obstructive Pulmonary Disease (COPD), and asthma as well as better methods for diagnosing cardiovascular diseases. The company's drug candidates includes RCD405, VAL001, RESP2000, RESP3000, RESP9000, and RESP1000.

Respiratorius AB Headlines

No Headlines